Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(9%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
9
82%
Ph phase_2
1
9%
Ph phase_4
1
9%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
1(9.1%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
9(81.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(6)
Other(1)

Detailed Status

Completed6
Not yet recruiting3
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (9.1%)
Phase 41 (9.1%)
N/A9 (81.8%)

Trials by Status

not_yet_recruiting327%
completed655%
recruiting19%
unknown19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
PROCEDURE
Total Trials
11